|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2007-11-12
|
|
pubmed:abstractText |
Tumor-associated-trypsin inhibitor (TATI) is frequently coexpressed with trypsinogen in tumors. Recently, we found expression of trypsinogens in prostate cancer. We have now studied whether TATI is also expressed in prostate cancer and if TATI expression is associated with Gleason grade, proliferation, and neuroendocrine differentiation.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0302-2838
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
52
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1670-9
|
|
pubmed:meshHeading |
pubmed-meshheading:17306443-Aged,
pubmed-meshheading:17306443-Aged, 80 and over,
pubmed-meshheading:17306443-Cell Line, Tumor,
pubmed-meshheading:17306443-Gene Expression Regulation,
pubmed-meshheading:17306443-Humans,
pubmed-meshheading:17306443-Immunohistochemistry,
pubmed-meshheading:17306443-In Situ Hybridization,
pubmed-meshheading:17306443-Male,
pubmed-meshheading:17306443-Metribolone,
pubmed-meshheading:17306443-Middle Aged,
pubmed-meshheading:17306443-Prostatic Neoplasms,
pubmed-meshheading:17306443-Tissue Array Analysis,
pubmed-meshheading:17306443-Trypsin Inhibitor, Kazal Pancreatic
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cells.
|
|
pubmed:affiliation |
Department of Clinical Chemistry, Helsinki University Central Hospital, Helsinki, Finland. annukka.paju@hus.fi
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
